Differential expression of muscarinic acetylcholine receptor subtypes in Jurkat cells and their signaling

Journal of Neuroimmunology

Volumn 237, Issue 1-2, 2011, Pages 13-22

  Alea, Mileidys Perez ^a,b   Borroto Escuela, Dasiel O ^c   Romero Fernandez, Wilber ^c   Fuxe, Kjell ^c   Garriga, Pere ^a  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^b ASTON UNIVERSITY   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

G protein coupled receptors; Immunopharmacology; Lymphocytes; Muscarinic acetylcholine receptors; Signal transduction

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; PHOSPHOLIPASE C; PROTEIN KINASE C; RECEPTOR SUBTYPE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TIME;

HUMANS; JURKAT CELLS; MUSCARINIC ANTAGONISTS; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M4; RECEPTOR, MUSCARINIC M5; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 80051474913     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.05.010     Document Type: Article

References (45)

1. Abrams P., Andersson K.E., Buccafusco J.J., Chapple C., de Groat W.C., Fryer A.D., Kay G., Laties A., Nathanson N.M., Pasricha P.J., Wein A.J. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br. J. Pharmacol. 2006, 148:565-578.
2. Adem A., Karlsson E. Muscarinic receptor subtype selective toxins. Life Sci. 1997, 60:1069-1076.
3. Alberola-Ila J., Takaki S., Kerner J.D., Perlmutter R.M. Differential signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 1997, 15:125-154.
4. Bohme T.M., Augelli-Szafran C.E., Hallak H., Pugsley T., Serpa K., Schwarz R.D. Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors. J. Med. Chem. 2002, 45:3094-3102.
5. Bonner T.I., Buckley N.J., Young A.C., Brann M.R. Identification of a family of muscarinic acetylcholine receptor genes. Science 1987, 237:527-532.
6. Borroto-Escuela D.O., Garcia-Negredo G., Garriga P., Fuxe K., Ciruela F. The M(5) muscarinic acetylcholine receptor third intracellular loop regulates receptor function and oligomerization. Biochim Biophys Acta 2010, 1803:813-825.
7. Caulfield M.P., Birdsall N.J. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 1998, 50:279-290.
8. Choppin A., Eglen R.M. Pharmacological characterization of muscarinic receptors in mouse isolated urinary bladder smooth muscle. Br. J. Pharmacol. 2001, 133:1035-1040.
9. Diaz-Flores E., Siliceo M., Martinez A.C., Merida I. Membrane translocation of protein kinase Ctheta during T lymphocyte activation requires phospholipase C-gamma-generated diacylglycerol. J. Biol. Chem. 2003, 278:29208-29215.
10. Dittman A.H., Weber J.P., Hinds T.R., Choi E.J., Migeon J.C., Nathanson N.M., Storm D.R. A novel mechanism for coupling of m4 muscarinic acetylcholine receptors to calmodulin-sensitive adenylyl cyclases: crossover from G protein-coupled inhibition to stimulation. Biochemistry 1994, 33:943-951.
11. Firth T.A., Jones S.V. GTP-binding protein Gq mediates muscarinic-receptor-induced inhibition of the inwardly rectifying potassium channel IRK1 (Kir 2.1). Neuropharmacology 2001, 40:358-365.
12. Fujii T., Takada-Takatori Y., Kawashima K. Roles played by lymphocyte function-associated antigen-1 in the regulation of lymphocytic cholinergic activity. Life Sci. 2007, 80:2320-2324.
13. Fujino H., Kitamura Y., Yada T., Uehara T., Nomura Y. Stimulatory roles of muscarinic acetylcholine receptors on T cell antigen receptor/CD3 complex-mediated interleukin-2 production in human peripheral blood lymphocytes. Mol. Pharmacol. 1997, 51:1007-1014.
14. Fujino H., Uehara T., Murayama T., Okuma Y., Ariga H., Nomura Y. Extracellular signal regulated protein kinase and c-jun N-terminal kinase are involved in ml muscarinic receptor-enhanced interleukin-2 production pathway in Jurkat cells. Biol. Pharm. Bull. 2000, 23:1198-1205.
15. Gudermann T., Grosse R., Schultz G. Contribution of receptor/G protein signaling to cell growth and transformation. Naunyn Schmiedebergs Arch. Pharmacol. 2000, 361:345-362.
16. Gutkind J.S. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 1998, 273:1839-1842.
17. Hellstrom-Lindahl E., Nordberg A. Muscarinic receptor subtypes in subpopulations of human blood mononuclear cells as analyzed by RT-PCR technique. J. Neuroimmunol. 1996, 68:139-144.
18. Hornigold D.C., Mistry R., Raymond P.D., Blank J.L., Challiss R.A. Evidence for cross-talk between M2 and M3 muscarinic acetylcholine receptors in the regulation of second messenger and extracellular signal-regulated kinase signalling pathways in Chinese hamster ovary cells. Br. J. Pharmacol. 2003, 138:1340-1350.
19. Isakov N., Altman A. Protein kinase C(theta) in T cell activation. Annu. Rev. Immunol. 2002, 20:761-794.
20. Ishii M., Kurachi Y. Muscarinic acetylcholine receptors. Curr. Pharm. Des. 2006, 12:3573-3581.
21. Kaneda T., Kitamura Y., Nomura Y. Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line. Mol. Pharmacol. 1993, 43:356-364.
22. Kawashima K., Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol. Ther. 2000, 86:29-48.
23. Kawashima K., Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 2003, 74:675-696.
24. Kozma R., Sarner S., Ahmed S., Lim L. Rho family GTPases and neuronal growth cone remodelling: relationship between increased complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid. Mol. Cell. Biol. 1997, 17:1201-1211.
25. Lazareno S., Birdsall N.J. Pharmacological characterization of acetylcholine-stimulated [35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies. Br. J. Pharmacol. 1993, 109:1120-1127.
26. Lazareno S., Buckley N.J., Roberts F.F. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells. Mol. Pharmacol. 1990, 38:805-815.
27. Linseman D.A., Heidenreich K.A., Fisher S.K. Stimulation of M3 muscarinic receptors induces phosphorylation of the Cdc42 effector activated Cdc42Hs-associated kinase-1 via a Fyn tyrosine kinase signaling pathway. J. Biol. Chem. 2001, 276:5622-5628.
28. Nahorski S.R., Tobin A.B., Willars G.B. Muscarinic M3 receptor coupling and regulation. Life Sci. 1997, 60:1039-1045.
29. Nelson C.P., Challiss R.A. "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem. Pharmacol. 2007, 73:737-751.
30. Nomura J., Hosoi T., Okuma Y., Nomura Y. The presence and functions of muscarinic receptors in human T cells: the involvement in IL-2 and IL-2 receptor system. Life Sci. 2003, 72:2121-2126.
31. Okuma Y., Nomura Y. Roles of muscarinic acetylcholine receptors in interleukin-2 synthesis in lymphocytes. Jpn. J. Pharmacol. 2001, 85:16-19.
32. Olianas M.C., Onali P. PD 102807, a novel muscarinic M4 receptor antagonist, discriminates between striatal and cortical muscarinic receptors coupled to cyclic AMP. Life Sci. 1999, 65:2233-2240.
33. Onali P., Olianas M.C. Bimodal regulation of cyclic AMP by muscarinic receptors. Involvement of multiple G proteins and different forms of adenylyl cyclase. Life Sci. 1995, 56:973-980.
34. Paula F.M., Barbosa H.C., Carneiro E.M., Persaud S.J., Gagliardino J.J., Boschero A.C., Souza K.L. Requirement of NF-kappaB signalling pathway for modulation of the cholinergic muscarinic M3 receptor expression by INGAP-PP in insulin-producing cells. Eur J Pharmacol 2010, 642:37-46.
35. Reever C.M., Ferrari-DiLeo G., Flynn D.D. The M5 (m5) receptor subtype: fact or fiction?. Life Sci. 1997, 60:1105-1112.
36. Rinner I., Felsner P., Falus A., Skreiner E., Kukulansky T., Globerson A., Hirokawa K., Schauenstein K. Cholinergic signals to and from the immune system. Immunol. Lett. 1995, 44:217-220.
37. Roszman T.L., Jackson J.C., Cross R.J., Titus M.J., Markesbery W.R., Brooks W.H. Neuroanatomic and neurotransmitter influences on immune function. J. Immunol. 1985, 135:769s-772s.
38. Sato K.Z., Fujii T., Watanabe Y., Yamada S., Ando T., Kazuko F., Kawashima K. Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci. Lett. 1999, 266:17-20.
39. Schaeffer H.J., Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 1999, 19:2435-2444.
40. Schmidt M., Rumenapp U., Keller J., Lohmann B., Jakobs K.H. Regulation of phospholipase C and D activities by small molecular weight G proteins and muscarinic receptors. Life Sci. 1997, 60:1093-1100.
41. Shi H., Wang H., Wang Z. Identification and characterization of multiple subtypes of muscarinic acetylcholine receptors and their physiological functions in canine hearts. Mol. Pharmacol. 1999, 55:497-507.
42. Volpicelli L.A., Levey A.I. Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog. Brain Res. 2004, 145:59-66.
43. Watson N., Daniels D.V., Ford A.P., Eglen R.M., Hegde S.S. Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells. Br. J. Pharmacol. 1999, 127:590-596.
44. Yamada M., Inanobe A., Kurachi Y. G protein regulation of potassium ion channels. Pharmacol. Rev. 1998, 50:723-760.
45. Zimring J.C., Kapp L.M., Yamada M., Wess J., Kapp J.A. Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway. J. Neuroimmunol. 2005, 164:66-75.